| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,748 |
12,595 |
$1.62M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,298 |
16,951 |
$1.43M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,932 |
4,717 |
$688K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16,462 |
15,513 |
$580K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,703 |
3,940 |
$553K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,478 |
3,350 |
$434K |
| 96127 |
|
16,819 |
15,907 |
$338K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,507 |
10,844 |
$264K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,800 |
1,642 |
$213K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,518 |
2,332 |
$117K |
| 99173 |
|
8,769 |
8,312 |
$59K |
| 99174 |
|
2,668 |
2,430 |
$46K |
| 36416 |
|
11,229 |
10,677 |
$35K |
| 96161 |
|
1,651 |
1,505 |
$32K |
| D0145 |
Oral evaluation for a patient under three years of age |
5,101 |
4,872 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,382 |
1,273 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
992 |
914 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
344 |
300 |
$7K |
| 99442 |
|
197 |
181 |
$7K |
| 87634 |
|
103 |
101 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
76 |
73 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
33 |
31 |
$2K |
| 96160 |
|
102 |
95 |
$2K |
| 99401 |
|
106 |
104 |
$2K |
| 94760 |
|
991 |
893 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
14 |
$540.96 |
| 83655 |
|
34 |
34 |
$393.04 |
| 85018 |
|
11,255 |
10,693 |
$6.55 |
| 90671 |
|
482 |
431 |
$0.57 |
| 90686 |
|
4,521 |
4,245 |
$0.05 |
| 97802 |
|
17,747 |
16,788 |
$0.00 |
| 99000 |
|
2,324 |
2,144 |
$0.00 |
| 90680 |
|
686 |
627 |
$0.00 |
| 90723 |
|
715 |
695 |
$0.00 |
| 90647 |
|
630 |
607 |
$0.00 |
| 90619 |
|
58 |
51 |
$0.00 |
| 90697 |
|
350 |
258 |
$0.00 |
| 90656 |
|
129 |
126 |
$0.00 |
| 90674 |
|
637 |
625 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 99441 |
|
12 |
12 |
$0.00 |
| 90651 |
|
55 |
54 |
$0.00 |
| 99072 |
|
5,419 |
4,842 |
$0.00 |
| 90461 |
|
7,333 |
6,864 |
$0.00 |
| 99071 |
|
8,794 |
8,362 |
$0.00 |
| 90670 |
|
1,603 |
1,553 |
$0.00 |
| 90633 |
|
301 |
293 |
$0.00 |
| 81002 |
|
5,436 |
5,226 |
$0.00 |
| 90710 |
|
77 |
75 |
$0.00 |
| 90685 |
|
197 |
190 |
$0.00 |
| 90661 |
|
370 |
362 |
$0.00 |
| 90734 |
|
67 |
66 |
$0.00 |
| 90672 |
|
13 |
13 |
$0.00 |